Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance.
about
Drug-resistant and hospital-associated Enterococcus faecium from wastewater, riverine estuary and anthropogenically impacted marine catchment basinGenetic diversity among Enterococcus faecalisMolecular Identification of Multiple Antibiotic Resistant Fish Pathogenic Enterococcus faecalis and their Control by Medicinal Herbs.CARRIAGE OF MULTIDRUG RESISTANT ENTEROCOCCUS FAECIUM AND ENTEROCOCCUS FAECALIS AMONG APPARENTLY HEALTHY HUMANS.Influence of First-Line Antibiotics on the Antibacterial Activities of Acetone Stem Bark Extract of Acacia mearnsii De Wild. against Drug-Resistant Bacterial Isolates.Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.Outer membrane lipoprotein Lpp is Gram-negative bacterial cell surface receptor for cationic antimicrobial peptidesLarge-scale screening of a targeted Enterococcus faecalis mutant library identifies envelope fitness factors.Differential expression of virulence-related genes in Enterococcus faecalis in response to biological cues in serum and urineEfrAB, an ABC multidrug efflux pump in Enterococcus faecalis.Pathogenicity islands in bacterial pathogenesisEnterococcus faecalis infection activates phosphatidylinositol 3-kinase signaling to block apoptotic cell death in macrophages.The polyamine N-acetyltransferase-like enzyme PmvE plays a role in the virulence of Enterococcus faecalis.Oxidative stress enhances cephalosporin resistance of Enterococcus faecalis through activation of a two-component signaling system.A review of the current place of glycopeptides in turkish medical practiceSurface protein EF3314 contributes to virulence properties of Enterococcus faecalis.SlyA is a transcriptional regulator involved in the virulence of Enterococcus faecalis.Reciprocal regulation of cephalosporin resistance in Enterococcus faecalis.Toxin-antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococci.A eukaryotic-type Ser/Thr kinase in Enterococcus faecalis mediates antimicrobial resistance and intestinal persistencePharmacogenomic strategies against resistance development in microbial infections.Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract.Genomic diversification of enterococci in hosts: the role of the mobilome.Emergence of clonal complex 17 Enterococcus faecium in The Netherlands.Mechanisms of resistance to daptomycin in Enterococcus faecium.Enterocin A mutants identified by saturation mutagenesis enhance potency towards vancomycin-resistant EnterococciMolecular characterization of vanA-containing Enterococcus from migratory birds: song thrush (Turdus philomelos)Time-kill behaviour against eight bacterial species and cytotoxicity of antibacterial monomers.Prevalence of aac(6')-Ie-aph(2″)-Ia resistance gene and its linkage to Tn5281 in Enterococcus faecalis and Enterococcus faecium isolates from Tabriz hospitals.Nutritional control of antibiotic resistance via an interface between the phosphotransferase system and a two-component signaling system.Thymidylate Limitation Potentiates Cephalosporin Activity toward Enterococci via an Exopolysaccharide-Based Mechanism.Genetic basis for vancomycin-enhanced cephalosporin susceptibility in vancomycin-resistant enterococci revealed using counterselection with dominant-negative thymidylate synthase.Antimicrobial resistance among Gram-positive pathogens in Saudi Arabia.Local genetic patterns within a vancomycin-resistant Enterococcus faecalis clone isolated in three hospitals in Portugal.Extracellular SalB contributes to intrinsic cephalosporin resistance and cell envelope integrity in Enterococcus faecalis.Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology.Structure and Dimerization of IreB, a Negative Regulator of Cephalosporin Resistance in Enterococcus faecalis.Population structure of Enterococcus faecium causing bacteremia in a Spanish university hospital: setting the scene for a future increase in vancomycin resistance?Harnessing bacteriocin biology as targeted therapy in the GI tract.Enhancing the Anti-Enterococci Activity of Different Antibiotics by Combining With Metal Oxide Nanoparticles.
P2860
Q21093354-06B00834-89BF-4F5D-97BB-FF8110EF949BQ33289954-27437BC1-CE7C-4EDF-AD50-E70B547E3FF1Q33807827-946B9403-D3AD-4704-9629-0771A6588FFDQ33813472-6721C970-D4EF-42FF-8525-0444E1572B54Q33914695-91E40772-1E43-48C1-A625-65339BB8785EQ33938255-673B17E8-1A67-4BF1-88AF-50D51D285368Q34074686-BB52F37B-DACF-4DFF-A7ED-48AEBEE6033FQ34110655-AEC69762-0761-46DE-B0A4-967E9EEE7685Q34127412-88BFD389-BD88-4872-870C-B68083F3BBDCQ34230365-7AAAE818-93D6-4CE2-A6FC-65206973B048Q34290188-869D722D-BC9E-416F-8FF8-93D058B18434Q34595877-5E016D46-F7B0-427E-9CA4-4157430C8DB9Q34889985-E938DA61-51C5-4CC9-AC8F-FD3FA5559E19Q34922146-4D350301-1DDF-4E2A-8E8D-F3BB2B6DFD7AQ35134138-EAA3D910-BF8C-47A8-A00F-BE42135B9133Q35153709-E44D47F9-99F0-4E9D-964B-53A7796A963EQ35329262-90897515-DA42-4F47-B32A-0017216E94E5Q35458177-8DF9B0F7-C4C6-47A3-8FF4-8CDD1F29595FQ35576011-E3C3648C-22F4-4154-9987-229FEE8F62E5Q35652451-88E60949-8431-4E28-9CC1-1E869E9FE7E0Q35785222-42963359-5EFE-4265-B6B2-AEE6D9CB8361Q35812024-E9019DE2-C372-40D6-984B-3CA1593211DAQ35828450-CC0F4D33-FAB6-4E7F-80A0-D705BEF963D7Q36423673-2A76F1F4-78E8-4757-A8B3-8E3AC15FC930Q36482920-9D8E1B88-AA49-4AF1-A775-E5524B75BE88Q36764449-2BA353F3-CAF5-44A4-A684-612F35A53F51Q37160010-9BA89FE5-1930-47FF-B851-0635B1FBB00AQ37353731-D340E262-44DC-4035-9121-E423DF76F259Q37492790-9B3B8017-538E-4F44-93B2-2989D558CA20Q37544839-8EE39C6A-1F6C-4F19-B942-8355A20D627AQ37587654-0B5FA30D-F1F5-489F-A8C1-80F38E6EA0D4Q37643711-DA6F69CD-7E75-4A7D-9E6B-0130C019FB7CQ38023661-ABC93F2C-25B5-4311-9DB2-7572DAEB5097Q39954529-D2098387-A7A4-4653-BD2A-5AE3E903DA0AQ40065904-409A3A5B-7D0F-49D7-81A4-118A76B7EE21Q40084231-DF0AE393-D0CA-4408-B14C-5BBD85B89B6AQ40196576-D3D66B3D-F75A-4723-B52F-8C3F41DEE43CQ40410647-092FF2CC-4029-4A35-B639-A1A2E142F61FQ40471187-5303A14D-ECFF-4141-A072-8ACF99AAD770Q40658849-794A38F2-6CDA-4C22-8833-870234D9E578
P2860
Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Antibiotic-resistant enterococ ...... g introduction and resistance.
@ast
Antibiotic-resistant enterococ ...... g introduction and resistance.
@en
Antibiotic-resistant enterococ ...... g introduction and resistance.
@nl
type
label
Antibiotic-resistant enterococ ...... g introduction and resistance.
@ast
Antibiotic-resistant enterococ ...... g introduction and resistance.
@en
Antibiotic-resistant enterococ ...... g introduction and resistance.
@nl
prefLabel
Antibiotic-resistant enterococ ...... g introduction and resistance.
@ast
Antibiotic-resistant enterococ ...... g introduction and resistance.
@en
Antibiotic-resistant enterococ ...... g introduction and resistance.
@nl
P1476
Antibiotic-resistant enterococ ...... g introduction and resistance.
@en
P2093
Brett D Shepard
Michael S Gilmore
P304
P356
10.1016/S1286-4579(01)01530-1
P577
2002-02-01T00:00:00Z